Table 6.
Compounds identified using ROCS shape-based virtual screening
| Compd | R1 | R2 | Ring | n | IC50 (μM) | Kd (μM) | Activation of Viral Infectivity |
|---|---|---|---|---|---|---|---|
| 41 | Cl | H | ![]() |
67 | 73.7 | 3.7 (5) | 1.0 |
| 42 | Cl | H | ![]() |
1 | 58.6 | N.D. | 0.0 |
| 43 | Cl | F | ![]() |
3 | 85.2 ± 14.8 | 2.1 | 0.0 |
| 44 | Cl | F | ![]() |
1 | > 100 | N.D. | 0.0 |
| 45 | Cl | F | ![]() |
2 | 58.5 ± 35.8 | N.B. | 0.0 |
| 46 | Cl | F | ![]() |
3 | 33.5 ± 9.1 | 1.7 | 0.3 |
| 47 | Cl | F | ![]() |
9 | 57.1 ± 14.2 | 2.4 | 0.48 ± 0.18 |
| 48 | Cl | F | ![]() |
1 | > 100 | N.D. | 0.1 |






